This federal contract award, valued at $5,025.15, was issued by the Medical Supply Chain division of the Defense Department to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed price purchase order with a completion date of July 11, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...
This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of 8510598440 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract is a firm fixed-price purchase order with a completion date of May 13, 2024. The Maclean Group LLC is an...
The federal contract award, valued at $4,020.12, was issued by the Medical Supply Chain agency of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510598613 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed-price purchase order contract with a completion date of May 13, 2024. The Maclean Group LLC is an ISO...
This federal contract award, valued at $1,005.03, was issued by the Defense agency Medical Supply Chain to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510987189 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. The Maclean Group LLC has secured this firm-fixed price purchase order with an ultimate completion date of November 13, 2024. The company has established...
The U.S. government's Defense agency, specifically the Medical Supply Chain, has awarded a $4,020.12 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, with a completion date of June 18, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
This federal contract award, valued at $1,005.03, was issued by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has an ultimate completion date of October 3, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been...
This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the U.S. Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is a firm-fixed-price purchase order for the delivery of 8510598494 ! NALOXONE HYDROCHLOR, a medical product, with a completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
This federal contract award, valued at $1,005.03, was made by the Defense Logistics Agency's Medical Supply Chain organization to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is a firm-fixed-price purchase order for the delivery of naloxone hydrochloride, to be completed by August 8, 2024. The Maclean Group holds several significant federal contract vehicles, including a $2.63 million Federal Supply Schedule...
This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...